Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Identifying dynapenia using ventilatory parameters in patients with heart failure with preserved ejection fraction: cross-sectional analysis of the FUNNEL+ study.

Revista clinica espanola·2026
Same author

The American Diabetes Association's Standards of Care in Diabetes - 2026: key aspects for the internist's clinical practice.

Revista clinica espanola·2026
Same author

Phenotype-Specific Mitochondrial Responses to Mediterranean Diet and Exercise in Elderly Obesity.

Nutrients·2026

Related Experiment Video

Updated: Jun 28, 2026

Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue
06:35

Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue

Published on: April 5, 2024

[Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].

Vivencio Barrios1, Ricardo Gómez-Huelgas, Rosario Rodríguez

  • 1Departamento de Cardiología, Hospital Ramón y Cajal, Madrid, Spain. vbarrios.hrc@salud.madrid.org

Revista Espanola De Cardiologia
|November 13, 2008
PubMed
Summary
This summary is machine-generated.

Low adiponectin and high hsCRP levels predict cardiovascular events. Emerging risk factors like obesity and triglycerides are also associated with CV events, but don't improve current risk scores.

More Related Videos

Isolation, Culture, and Adipogenic Induction of Stromal Vascular Fraction-derived Preadipocytes from Mouse Periaortic Adipose Tissue
06:56

Isolation, Culture, and Adipogenic Induction of Stromal Vascular Fraction-derived Preadipocytes from Mouse Periaortic Adipose Tissue

Published on: July 21, 2023

Related Experiment Videos

Last Updated: Jun 28, 2026

Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue
06:35

Studying Adipose Endothelial Cell/Adipocyte Cross-Talk in Human Subcutaneous Adipose Tissue

Published on: April 5, 2024

Isolation, Culture, and Adipogenic Induction of Stromal Vascular Fraction-derived Preadipocytes from Mouse Periaortic Adipose Tissue
06:56

Isolation, Culture, and Adipogenic Induction of Stromal Vascular Fraction-derived Preadipocytes from Mouse Periaortic Adipose Tissue

Published on: July 21, 2023

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Context:

  • Classic cardiovascular (CV) risk factors are insufficient for full risk stratification.
  • Emerging factors like adiponectin, glycosilated hemoglobin, waist circumference, and hsCRP offer additional insights.
  • Adiponectin is linked to insulin resistance, dyslipidemia, and coronary artery disease.

Purpose:

  • To investigate the relationship between adiponectin, other emerging risk factors, and CV events in the Spanish population.
  • To assess the predictive value of these factors in CV risk stratification.

Summary:

  • A low adiponectin level and high hsCRP level were associated with CV events.
  • Obesity and elevated triglycerides (≥150 mg/dL) 3 years prior also predicted events.
  • Plasma adiponectin showed an inverse relationship with waist circumference.

Impact:

  • Emerging risk factors, including adiponectin and hsCRP, are associated with CV events.
  • These factors do not enhance the predictive power of the SCORE algorithm.
  • Further research is needed to fully understand the contribution of emergent risk factors to CV risk assessment.